Xalkori is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Crizotinib.
Product ID | 0069-8140_19c4d302-9bf2-4557-8f22-f2c94341fd1a |
NDC | 0069-8140 |
Product Type | Human Prescription Drug |
Proprietary Name | Xalkori |
Generic Name | Crizotinib |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2011-08-26 |
Marketing Category | NDA / NDA |
Application Number | NDA202570 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | CRIZOTINIB |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Receptor Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2B6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2011-08-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202570 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-08-26 |
Ingredient | Strength |
---|---|
CRIZOTINIB | 250 mg/1 |
SPL SET ID: | 2a51b0de-47d6-455e-a94c-d2c737b04ff7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0069-8140 | Xalkori | CRIZOTINIB |
0069-8141 | Xalkori | CRIZOTINIB |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XALKORI 85069606 3967863 Live/Registered |
Pfizer Inc. 2010-06-23 |